393 related articles for article (PubMed ID: 33816483)
1. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration.
Fu Y; Bao Q; Liu Z; He G; Wen J; Liu Q; Xu Y; Jin Z; Zhang W
Front Cell Dev Biol; 2021; 9():633607. PubMed ID: 33816483
[TBL] [Abstract][Full Text] [Related]
2. Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration.
Fu Y; He G; Liu Z; Wang J; Zhang Z; Bao Q; Wen J; Jin Z; Zhang W
J Inflamm Res; 2021; 14():6719-6734. PubMed ID: 34916821
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration.
Fu Y; Jin Z; Shen Y; Zhang Z; Li M; Liu Z; He G; Wu J; Wen J; Bao Q; Wang J; Zhang W
Transl Oncol; 2022 Aug; 22():101452. PubMed ID: 35598382
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma.
Zheng D; Wei Z; Guo W
Front Genet; 2022; 13():849789. PubMed ID: 35518353
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
Zhang F; Wang X; Bai Y; Hu H; Yang Y; Wang J; Tang Y; Ma H; Feng D; Li D; Han P
Front Genet; 2021; 12():670384. PubMed ID: 34122523
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma.
Zhang W; Lyu P; Andreev D; Jia Y; Zhang F; Bozec A
Front Cell Dev Biol; 2022; 10():974851. PubMed ID: 36578780
[No Abstract] [Full Text] [Related]
7. A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma.
Wang F; Yang K; Pan R; Xiang Y; Xiong Z; Li P; Li K; Sun H
Front Med (Lausanne); 2023; 10():1115759. PubMed ID: 37293295
[TBL] [Abstract][Full Text] [Related]
8. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract][Full Text] [Related]
9. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.
Zhang GZ; Wu ZL; Li CY; Ren EH; Yuan WH; Deng YJ; Xie QQ
Front Mol Biosci; 2021; 8():615084. PubMed ID: 34095215
[TBL] [Abstract][Full Text] [Related]
10. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
12. Identification and Development of an Age-Related Classification and Signature to Predict Prognosis and Immune Landscape in Osteosarcoma.
Hong J; Wang X; Yu L; Li J; Hu H; Mao W
J Oncol; 2022; 2022():5040458. PubMed ID: 36276293
[TBL] [Abstract][Full Text] [Related]
13. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
14. Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma.
Xiao B; Liu L; Li A; Xiang C; Wang P; Li H; Xiao T
Front Oncol; 2020; 10():607622. PubMed ID: 33384961
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
16. Identification of the Transcription Co-Factor-Related Gene Signature and Risk Score Model for Osteosarcoma.
Jin Z; Wu J; Lin J; Wang J; Shen Y
Front Genet; 2022; 13():862803. PubMed ID: 35734428
[TBL] [Abstract][Full Text] [Related]
17. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
18. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
Xu F; Yan J; Peng Z; Liu J; Li Z
Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
[TBL] [Abstract][Full Text] [Related]
20. Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma.
Wu F; Xu J; Jin M; Jiang X; Li J; Li X; Chen Z; Nie J; Meng Z; Wang G
Front Mol Biosci; 2021; 8():705148. PubMed ID: 35071320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
